These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Hellmich B; Flossmann O; Gross WL; Bacon P; Cohen-Tervaert JW; Guillevin L; Jayne D; Mahr A; Merkel PA; Raspe H; Scott DG; Witter J; Yazici H; Luqmani RA Ann Rheum Dis; 2007 May; 66(5):605-17. PubMed ID: 17170053 [TBL] [Abstract][Full Text] [Related]
6. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab. Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574 [TBL] [Abstract][Full Text] [Related]
7. [ANCA-associated forms of vasculitis]. Helmchen U; Kneissler U; Prall F Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and management of small vessel vasculitides]. Pettersson T; Karjalainen A Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753 [TBL] [Abstract][Full Text] [Related]
9. Review article: Progress of treatment in ANCA-associated vasculitis. Jayne D Nephrology (Carlton); 2009 Feb; 14(1):42-8. PubMed ID: 19335843 [TBL] [Abstract][Full Text] [Related]
11. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. Merkel PA; Seo P; Aries P; Neogi T; Villa-Forte A; Boers M; Cuthbertson D; Felson DT; Hellmich B; Hoffman GS; Jayne DR; Kallenberg CG; Krischer J; Mahr A; Matteson EL; Specks U; Luqmani R; Stone J; ; J Rheumatol; 2005 Dec; 32(12):2488-95. PubMed ID: 16331794 [TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney. Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665 [TBL] [Abstract][Full Text] [Related]
13. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials. Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740 [TBL] [Abstract][Full Text] [Related]
14. [Uptodate in the management and treatment of ANCA-associated vasculitis]. Belaconi IN; Toma CL; Bogdan MA Pneumologia; 2014; 63(2):78-80, 83-6. PubMed ID: 25241554 [TBL] [Abstract][Full Text] [Related]
15. [Renal vasculitis and glomerulonephritis with anti-neutrophil cytoplasmic antibody positivity]. Tesar V; Rychlík I; Bartůnková J; Stejsakalová A; Zabka J; Janatková I; Fucíková T; Becvár R Cas Lek Cesk; 1996 Jan; 135(3):79-83. PubMed ID: 8625374 [TBL] [Abstract][Full Text] [Related]
16. Evidence-based management of ANCA vasculitis. Carruthers D; Sherlock J Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):367-78. PubMed ID: 19508944 [TBL] [Abstract][Full Text] [Related]
17. Treatment of ANCA-associated systemic vasculitis. Belmont HM Bull NYU Hosp Jt Dis; 2006; 64(1-2):60-6. PubMed ID: 17121492 [TBL] [Abstract][Full Text] [Related]
18. Current state of biologicals in the management of systemic vasculitis. Lamprecht P; Till A; Steinmann J; Aries PM; Gross WL Ann N Y Acad Sci; 2007 Sep; 1110():261-70. PubMed ID: 17911441 [TBL] [Abstract][Full Text] [Related]
19. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis. Jones RB Nephron Clin Pract; 2014; 128(3-4):243-9. PubMed ID: 25401382 [TBL] [Abstract][Full Text] [Related]